Non-infectious uveitis represents a heterogenous group of immune-mediated ocular diseases, which can be associated with underlying systemic disease. While the initial choice of treatment of non-infectious uveitis depends on a number of factors such as anatomical location and degree of inflammation, topical therapies often remain the initial choice of non-invasive therapy. In this narrative review, we aim to describe the literature on non-infectious uveitis, with specific focus on the current perspective on topical anti-inflammatory therapy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9717596 | PMC |
| http://dx.doi.org/10.2147/JIR.S288294 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Minor salivary gland biopsy in the diagnosis of definite ocular sarcoidosis in paediatric granulomatous uveitis.
Pediatr Rheumatol Online J
March 2025
Paediatric Clinical Immunology, Pellegrin Hospital, INSERM CICP, University Hospital Centre of Bordeaux, Bordeaux, CIC1401, France.
Background: Non-infectious paediatric granulomatous uveitis (PGU) is a rare disease that is idiopathic in more than half of affected children. The diagnosis of definite ocular sarcoidosis (OS) must be supported by the presence of non-caseating granulomas detected in biopsy, and is therefore a challenge in children with PGU. This study investigated the utility of minor salivary gland biopsy (MSGB) in the diagnosis of definite OS in PGU.
View Article and Find Full Text PDFOutcomes in non-infectious uveitis patients treated with adalimumab in a tertiary eye care center.
J Fr Ophtalmol
March 2025
Department of Ophthalmology, Division of Uvea-Behçet Unit, Erciyes University Medical Faculty, Kayseri, Turkey.
Purpose: To evaluate the efficacy of adalimumab (ADA) treatment in non-infectious uveitis and the effect of disease duration, age, and etiology on treatment outcome.
Methods: This retrospective study included patients with active non-infectious uveitis who were on ADA treatment with at least 3 months follow-up from a single tertiary care center. Uveitis type, any associated systemic disease, uveitis duration before ADA, duration of ADA treatment, best-corrected visual acuity (BCVA), anterior chamber cell (ACC) grade, vitritis grade, intraocular pressure (IOP) values, central macular thickness (CMT), fundus fluorescein angiography (FFA) score, complications and relapse rate were recorded.
Comment on 'Incidence of non-infectious uveitis among patients with hidradenitis suppurativa': reply from authors.
Br J Dermatol
March 2025
Northwell, New Hyde Park, NY, USA.
Comment on 'Incidence of non-infectious uveitis among patients with hidradenitis suppurativa'.
Br J Dermatol
March 2025
Department of Ophthalmology, China Medical University Hospital, China Medical University, Taichung, Taiwan.
Anti-inflammatory actions of ripasudil ameliorate experimental autoimmune uveoretinitis in the acute phase.
BMJ Open Ophthalmol
February 2025
Department of Ophthalmology, National Defense Medical College, Tokorozawa, Saitama, Japan
Introduction: Rho-associated protein kinases (ROCKs) are a key regulator of T cell function, influencing a wide range of processes from activation to differentiation. Experimental autoimmune uveoretinitis (EAU) is an animal model of human non-infectious uveitis. This study aimed to evaluate the suppressive effects of ripasudil, a ROCK inhibitor, on ocular inflammation when administered from the onset of EAU and to elucidate the underlying mechanisms of its inhibitory effects.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!